Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2020 Feb 18

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Endocrinologica 2020 Feb 18

DOI: 10.23736/S0391-1977.20.03122-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway

Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6

1 Department of Nephrology, the People’s Hospital of Zhangqiu Area, Jinan, China; 2 Department of Pharmacy, Yidu Central Hospital of Weifang, Weifang, China; 3 Department of Pharmacy, Qingdao Central Hospital, Qingdao, China; 4 Ward Department, the People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Burn and Plastic Surgery, the People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Rehabilitation, the People’s Hospital of Zhangqiu Area, Jinan, China


PDF


top of page